FOSL1 and breast cancer: Fra1 was regarded as the gatekeeper for the mesenchymal-epithelial transition (MET) to EMT in breast cancer [21] and directly control the epithelial-mesenchymal plasticity in colorectal cancer (CRC) cells [22].